Lung cancer remains the leading cause of cancer-related mortality worldwide. Early detection of pulmonary nodules is crucial for timely diagnosis and effective treatment.
The best shot at curing cancer is catching it early, doctors say, but that doesn't always happen. Between 80% and 85% of pancreatic cancer cases aren't diagnosed until the aggressive and lethal ...
Lung cancer in never smokers is an increasingly recognized global health issue with distinct biological drivers, environmental risk factors, and genetic susceptibilities. Improved risk modelling, ...
Breakthrough research presented at the 2026 Society of Thoracic Surgeons Annual Meeting shows that additional lymph node evaluation is needed during surgery for non-small cell lung cancer (NSCLC) to ...
Researchers found an antibody that seems to play a role in people with better lung cancer prognoses, but turning it into a treatment could be difficult. By Gina Kolata Is there a way to use the body’s ...
JUPITER, Fla. — Although Lung Cancer Awareness Month is observed nationally in November, a woman who attended a Let’s Hear It meet-up said she would like to see awareness raised year-round. WPTV ...
Jan 20 (Reuters) - Bristol Myers Squibb (BMY.N), opens new tab said on Tuesday it had signed an agreement with Microsoft (MSFT.O), opens new tab to use the tech company's AI-enabled radiology platform ...
Bristol Myers Squibb (BMY) on Tuesday announced a collaboration with Microsoft (MSFT) to speed up early detection of lung cancer using the tech giant’s artificial intelligence-powered radiology ...
Microsoft and Bristol Myers Squibb have signed a new pact aimed at identifying lung cancer cases more quickly. The U.S. tech giant will provide its suite of artificial-intelligence-powered radiology ...
Jan 20 (Reuters) - Bristol Myers Squibb said on Tuesday it had signed an agreement with Microsoft to use the tech company's AI-enabled radiology platform to help speed up early detection of lung ...
Vancouver, British Columbia--(Newsfile Corp. - January 15, 2026) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTCQB: BMKDF) ("BioMark"), a leading developer of liquid biopsy technologies for ...
Labcorp is adding to its suite of tests designed to detect cancer recurrence much earlier than traditional imaging. The line includes the company’s Plasma Detect ID, a whole exome sequence-guided, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results